These compounds may interact with:
Nuclear receptor coactivator 1
Potentially involved in: cancer; kidney cancer; carcinoma; type 1 diabetes mellitus; endometriosis; mammary neoplasms, experimental; neoplasm metastasis; prostatic neoplasms; mammary neoplasms; acute quadriplegic myopathy; adult high grade glioma; aldosterone-producing adenoma; astrocytoma; atypical teratoid / rhabdoid tumor; breast cancer; glioblastoma; invasive ductal carcinoma; medulloblastoma, large-cell; osteosarcoma; ovarian cancer
Disease data sourced from Pharos.